Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gardasil 9 Dosing Schedules in West African Females
NCT03832049Phase 3Unknown
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Sep 2019
- Primary completion
- Jun 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection, sponsored by London School of Hygiene & Tropical Medicine. Status: unknown.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT03832049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03832049.